Detailed answers about SYNTHAGEN PHARMACEUTICAL LTD, including incorporation, status, business activity, and accounts information.
When was SYNTHAGEN PHARMACEUTICAL LTD founded?
SYNTHAGEN PHARMACEUTICAL LTD was officially incorporated on 20 August 2024 and is registered under company number 15908371. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SYNTHAGEN PHARMACEUTICAL LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SYNTHAGEN PHARMACEUTICAL LTD?
SYNTHAGEN PHARMACEUTICAL LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SYNTHAGEN PHARMACEUTICAL LTD do?
SYNTHAGEN PHARMACEUTICAL LTD operates in the following sectors: 46180 - Agents specialized in the sale of other particular products, 47190 - Other retail sale in non-specialised stores, 47910 - Retail sale via mail order houses or via Internet, 47990 - Other retail sale not in stores, stalls or markets. These SIC codes provide insight into the company's business activities and industry focus.
What is SYNTHAGEN PHARMACEUTICAL LTD's registered address?
The registered office address of SYNTHAGEN PHARMACEUTICAL LTD is OFFICE 614B, 182-184 HIGH STREET NORTH, EAST HAM, LONDON, UNITED KINGDOM, E6 2JA. This is the official address filed with Companies House for legal and statutory correspondence.
Is SYNTHAGEN PHARMACEUTICAL LTD financially stable?
Financial accounts for SYNTHAGEN PHARMACEUTICAL LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.